These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 16306272

  • 1. Glibenclamide-induced apoptosis is specifically enhanced by expression of the sulfonylurea receptor isoform SUR1 but not by expression of SUR2B or the mutant SUR1(M1289T).
    Hambrock A, de Oliveira Franz CB, Hiller S, Osswald H.
    J Pharmacol Exp Ther; 2006 Mar; 316(3):1031-7. PubMed ID: 16306272
    [Abstract] [Full Text] [Related]

  • 2. Resveratrol binds to the sulfonylurea receptor (SUR) and induces apoptosis in a SUR subtype-specific manner.
    Hambrock A, de Oliveira Franz CB, Hiller S, Grenz A, Ackermann S, Schulze DU, Drews G, Osswald H.
    J Biol Chem; 2007 Feb 02; 282(5):3347-56. PubMed ID: 17138562
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Tissue specificity of sulfonylureas: studies on cloned cardiac and beta-cell K(ATP) channels.
    Gribble FM, Tucker SJ, Seino S, Ashcroft FM.
    Diabetes; 1998 Sep 02; 47(9):1412-8. PubMed ID: 9726229
    [Abstract] [Full Text] [Related]

  • 6. Rat homolog of sulfonylurea receptor 2B determines glibenclamide sensitivity of ROMK2 in Xenopus laevis oocyte.
    Tanemoto M, Vanoye CG, Dong K, Welch R, Abe T, Hebert SC, Xu JZ.
    Am J Physiol Renal Physiol; 2000 Apr 02; 278(4):F659-66. PubMed ID: 10751228
    [Abstract] [Full Text] [Related]

  • 7. 17beta-Estradiol modulates apoptosis in pancreatic beta-cells by specific involvement of the sulfonylurea receptor (SUR) isoform SUR1.
    Ackermann S, Hiller S, Osswald H, Lösle M, Grenz A, Hambrock A.
    J Biol Chem; 2009 Feb 20; 284(8):4905-13. PubMed ID: 19095654
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Selectivity of repaglinide and glibenclamide for the pancreatic over the cardiovascular K(ATP) channels.
    Stephan D, Winkler M, Kühner P, Russ U, Quast U.
    Diabetologia; 2006 Sep 20; 49(9):2039-48. PubMed ID: 16865362
    [Abstract] [Full Text] [Related]

  • 15. Interaction of the sulfonylthiourea HMR 1833 with sulfonylurea receptors and recombinant ATP-sensitive K(+) channels: comparison with glibenclamide.
    Russ U, Lange U, Löffler-Walz C, Hambrock A, Quast U.
    J Pharmacol Exp Ther; 2001 Dec 20; 299(3):1049-55. PubMed ID: 11714894
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Coexpression with the inward rectifier K(+) channel Kir6.1 increases the affinity of the vascular sulfonylurea receptor SUR2B for glibenclamide.
    Russ U, Hambrock A, Artunc F, Löffler-Walz C, Horio Y, Kurachi Y, Quast U.
    Mol Pharmacol; 1999 Nov 20; 56(5):955-61. PubMed ID: 10531400
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.